Excessive expression of subunit 1 of GIRK1 in ER + breast tumors is associated with reduced survival times and increased lymph node metastasis in patients. To investigate possible tumor-initiating properties, benign MCF10A and malign MCF7 mammary epithelial cells were engineered to overexpress GIRK1 neoplasia associated vital parameters and resting potentials were measured and compared to controls. The presence of GIRK1 resulted in resting potentials negative to the controls. Upon GIRK1 overexpression, several cellular pathways were regulated towards pro-tumorigenic action as revealed by comparison of transcriptomes of MCF10A GIRK1 with the control (MCF10A eGFP ). According to transcriptome analysis, cellular migration was promoted while wound healing and extracellular matrix interactions were impaired. Vital parameters in MCF7 cells were affected akin the benign MCF10A lines, but to a lesser extent. Thus, GIRK1 regulated cellular pathways in mammary epithelial cells are likely to contribute to the development and progression of breast cancer.
Results
Validation and characterization of MEC lines overexpressing GIRK1. First, mRNA levels in the MEC lines generated were assessed by RT-qPCR ( Fig. 1A) . Expression of mRNA encoding GIRK1 was increased more than four orders of magnitude in MCF10A GIRK1 cells when compared to MCF10A WT , where GIRK1 mRNA was barely detectable (observed C T value as measured by qPCR was 35.26 ± 1.32 (mean ± SEM); N = 6). In comparison GIRK1 mRNA levels were more than two orders of magnitude higher in the malign MCF7 WT vs. the benign MCF10A WT (p < 0.001). Overexpression of GIRK1 caused a further increase of mRNA levels by two orders of magnitude in MCF7 GIRK1 when compared to MCF7 WT . mRNA expression levels of control cell lines (MCF10A eGFP & MCF7 eGFP ) resembled the respective wild type lines. Secondly, GIRK1 protein expression was assessed by Western blot (WB) analysis (Fig. 1B) . GIRK1 protein was clearly detected in both MCF10A GIRK1 and MCF7 GIRK1 lines by Western Blot (WB) analysis, while being barely detectable in the corresponding WT and control lines. Although mRNA levels encoding GIRK1 were substantial in MCF7 WT , corresponding protein amounts could not be reliably detected by WB. Immunoprecipitation (IP) was performed on MCF7 WT using antibody (Ab) directed against GIRK1 C-terminus (C-T; Fig. 1C ). GIRK1 protein was not only detected in the precipitate when tested with GIRK1 CT Ab, but also with GIRK1 NT Ab or monoclonal GIRK1 Ab that recognize different epitopes on the GIRK1 protein. In summary, we could verify that the MCF10A GIRK1 and MCF7 GIRK1 transfectant cell lines exhibit relevant overexpression of GIRK1 mRNA and protein compared to the respective WT lines. In addition, GIRK1 mRNA and protein levels are substantial in the malign estrogen receptor positive MCF7 WT line compared to the benign MCF10A WT MEC line. Thus, the set of cell lines generated pose a plausible model to study functional effects of elevated GIRK1 levels in benign and malignant MECs. GIRK1 overexpression produces functional GIRK channels both in MCF10A and MCF7 based MEC lines. In MCF10A GIRK1 membrane resting potentials (RPs) were −52.8 ± 4.5 mV (mean value ± SEM) and hyperpolarized when compared to controls that ranged around −24 mV (MCF10A WT : −24.3 ± 3.2 mV, MCF10A eGFP : −24.5 ± 3.6 mV; Fig. 2A ). In the presence of 200 nmol/L tertiapin-Q, a specific blocker of GIRK1 containing GIRK channels 19, 20 , RPs approached and exceeded control values (−19.0 ± 2.3 mV), indicating that overexpressed GIRK1 protein produces functional K + channels in MCF10A. RPs were assessed in the MCF7 based cell lines described here and, in addition, in MCF7 based cell lines, stably overexpressing chimeric GIRK1/ eYFP protein, described previously ( 18 ; Fig. 2B (see Supplementary Figure 1 for GIRK1 mRNA levels of chimeric vs. bicistronic MCF7 lines)). Both MCF7 GIRK1 and MCF7 GIRK1/eYFP exerted hyperpolarized RPs when compared to respective controls, albeit the differences in RPs between overexpressors and control groups were less pronounced in comparison to benign MCF10A lines. Moreover, when GIRK channels were blocked by tertiapin-Q in MCF7 GIRK1 , RPs with −17.0 ± 4.3 mV were the most depolarized among MCF7 based lines and considerably higher when compared to MCF7 WT (−27.2 ± 3.1 mV). These observations demonstrate that functional GIRK channels formed upon overexpression of GIRK1 in the malignant MCF7 and in the benign MCF10A MEC lines. In addition, minute amounts of functional GIRK channel complexes already preexist in MCF7 WT , corresponding to the moderate GIRK1 mRNA and protein levels.
GIRK1 overexpression triggers several pro-tumorigenic pathways in benign MECs. In order
to identify a possible cancerogenic influence of GIRK1 overexpression in benign MECs, transcriptomes of MCF10A GIRK1 were compared to the ones of MCF10A eGFP . Unexpected for the overexpression of a single K + channel subunit, a high number of transcripts were sizably up-or downregulated upon GIRK1 overexpression (Fig. 3A ). Analysis and classification into functionally related groups of genes using the Database for Annotation, Visualization and Integrated Discovery (DAVID) revealed that many of these transcripts are regulated towards specific cellular functions and pro-tumorigenic action. In Fig. 3B , significantly regulated clusters that were of interest are shown (see discussion section for detailed consideration of pathways and the role of individual components in breast cancer). Enrichment scores (ES), p-values and FDRs for all significant clusters are shown in Supplementary Table S3 . Heat maps of selected clusters are shown in Fig. 3C , displaying the quantitative effect that underscores the amount of cellular regulation exerted by GIRK1 overexpression (Fig. 3C ). Heat maps of all significantly enriched clusters are shown in Supplementary Figures S3, S4.
GIRK1 overexpression promotes cellular migration. GIRK1 overexpression in MCF10A triggered
the downregulation of GO clusters about cell migration, motility, and locomotion (In particular GO:0006928, GO:0030335, GO:2000147, GO:0051272, GO:0040017, GO:0040011, GO:0030334, GO:2000145, GO:0040012, GO:0016477, GO:0051270, GO:0051674, GO:0048870, GO:0006935 and GO:0042330; see also Supplementary  Table 3 ). Many genes in these GO terms promote cellular migration and metastatic spread of tumor cells (see discussion section for selected examples). The fact that GIRK1 overexpression leads to downregulation of these GO terms and genes prompts to study cellular motility and velocity of the MCF10A and MCF7 based cell lines. GIRK1 overexpression greatly enhanced migration of MCF10A as assessed via cellular motility coefficient ( Fig. 4 ; see supplementary videos for representative examples of each experimental group (MCF10A_GIRK1_motility. mp4; MCF10A_eGFP_motility.mp4; MCF10A_WT_motility.mp4; MCF7_GIRK1_motility.mp4; MCF7_eGFP_ motility.mp4 and MCF7_WT_motility.mp4)). Accordingly, cellular velocities were substantially increased ( Fig. 5 ). Enhanced migration could also be observed in malignant MCF7 GIRK1 cells, but the effect was muted compared to MCF10A. The most motile third of MCF7 GIRK1 cells displayed increased cell motility when compared to MCF7 eGFP , while cellular velocities were virtually unchanged (Figs. 6, 7).
GIRK1 overexpression defers wound healing in benign MECs. Collective cell migration in adult-
hood takes place exclusively during tissue repair, e.g. when collective migration of epidermal sheets occurs across the provisional wound-bed, leading to epidermal wound closure. Similar to formative collective movements during growth and regeneration in the sound body, collective movement also occurs in cancer but aggravates the course of disease 21 . Wound healing rates of MCF10A GIRK1 cells were substantially reduced when compared to controls (MCF10A WT and MCF10A GFP ; Fig. 8 ; see supplementary videos for representative examples of each experimental group (MCF10A_GIRK1_WH.mp4; MCF10A_eGFP_WH.mp4; MCF10A_WT_WH.mp4; MCF7_ GIRK1_WH.mp4; MCF7_eGFP_WH.mp4 and MCF7_WT_WH.mp4)). In contrast, overexpression of GIRK1 led to a small increase of the wound healing rate in MCF7 cells (this increase was not statistically significant). In summary, our results demonstrate that GIRK1 expression has a distinct influence on wound healing in the malign and benign MEC lines.
Extracellular matrix interactions of benign MECs are hampered by GIRK1 overexpression.
MCF10A GIRK1 differed markedly to MCF10A eGFP regarding surface adherence properties as revealed by adhesion to surface coated with different extracellular matrix (ECM) molecules ( Fig. 9 ). Of note, the most prominently transcriptionally deregulated gene cluster in MCF10A GIRK1 /MCF10A eGFP is predicted to weaken interaction of cells with ECM molecules upon downregulation. Collagen I, collagen IV, fibronectin and tenascin-C adherence were hampered by GIRK1 overexpression. The interaction with laminin-coated surface was also weaker, but Proliferation of MEC in culture remains unchanged upon GIRK1 overexpression. Transcriptome analysis revealed profound downregulation of several gene clusters that predict augmentation of cell division, chromosome segregation and cellular proliferation. This led us to expect a strong impact of GIRK1 overexpression on cellular proliferation. In contrast to our expectations, proliferation of MECs in culture was virtually unaffected upon GIRK1 overexpression, both in MCF10A as well as in MCF7 cells ( Fig. 10) . Similarly, colony www.nature.com/scientificreports www.nature.com/scientificreports/ formation assay did not reveal any change between MEC lines in their ability to form colonies, nor in the growth rate of the colonies formed (Supplementary Figure S2 ).
GIRK1 overexpression in MCF10A does not interfere with neovascularisation. To address
the neovascularization potential of MCF10A GIRK1 , the chick chorioallantoic membrane (CAM) assay was performed. Neovascularization of MCF10A GIRK1 onplants by the host equaled controls (MCF10A eGFP & MCF10A WT ; Fig. 11A,B ). Accordingly, gene clusters responsible for neovascularization were unchanged in MCF10A GIRK1 when compared to MCF10A eGFP . Also in malignant MECs, GIRK1 overexpression turned out to be ineffective for neovascularization, when MCF7 GIRK1/eYFP cells displayed vascularization scores close to control 18 . GIRK1 overexpression in MCF10A GIRK1 induced, however, a massive spread of onplant area, when compared to controls (MCF10A eGFP & MCF10A WT ; Fig. 11C ), being in line with the observed reduced cell adhesion induced by GIRK1 overexpression.
Discussion
The present study demonstrates that overexpression of GIRK1 in benign MECs triggers a profound transcriptional response, which includes numerous genes involved in several cellular pro-tumorigenic pathways. In addition, GIRK1 overexpression in MCF10A results in tertiapin-Q sensitive hyperpolarization of resting potential, www.nature.com/scientificreports www.nature.com/scientificreports/ indicating that GIRK1 overexpression leads to the formation of functional transmembrane GIRK channels that are already active to some basic extent, even in the absence of agonists. Agonist independent, basal, activity of GIRK channels indicates the abundance of endogenous free Gβ/γ dimers 22 . Since additional GIRK isoforms, other than GIRK1, are thought to be indispensable for functional heterotetrameric K + channel formation 1 , the question arises whether GIRK1 isoforms are present in MECs. GIRK4 protein pre-exists in benign MECs, including MCF10A 17 , while GIRK4 and GIRK2 have been identified in the malign MCF7 line 16 . In the malign MCF7 line, GIRK1 overexpression resulted in hyperpolarized membrane resting potential. The effect was less pronounced in comparison to MCF10A. Blocking of GIRK channels in MCF7 GIRK1 by tertiapin-Q results in even stronger depolarization compared to the MCF7 control groups. We attribute the value of resting membrane www.nature.com/scientificreports www.nature.com/scientificreports/ potentials in the controls to moderate overexpression of GIRK1 that is already preexisting in the malignant MCF7 line 17 . Similar to the observed effect on the membrane resting potential, silencing of preexisting GIRK complexes in MCF7 by overexpression of the dominant negative splice variant GIRK1d, had a bearing on several vital functions of MCF7 cells which were in opposition to the ones of the functional GIRK1a variant 18 . Thus, preexisting GIRK complexes already act electrogenic and exert regulatory actions on cellular properties of the malignant MCF7 cell line. The effects induced by GIRKs are further increased upon ectopic GIRK1 overexpression in MCF7. Upon GIRK1 overexpression, the motility and cellular velocities of the benign MCF10A control cell lines were substantially increased and associated with transcriptional changes of genes that are linked to motility at the www.nature.com/scientificreports www.nature.com/scientificreports/ cellular level as shown in the heat map "Cell migration" (Fig. 3C ). Apart from their effect on cellular motility, the following genes are important in mammary carcinogenesis and breast cancer progression: IL-1ß is pivotal for pathogenesis and is understood to contribute to the poor prognosis of estrogen-dependent breast cancers 23 . Homozygous deletions of DOCK8 exist in breast cancer and lung cancer 24 . Reduced CCBE1 expression has www.nature.com/scientificreports www.nature.com/scientificreports/ shown to result in increase of invasive capacity in breast cancer cells and to lead to poor clinical prognosis in patients 25 . In benign MECs, Notch-1 activation triggers downregulation of LAMC2 resulting in cellular responses towards cancer hallmarks, including cell migration 26 . MTSS1 downregulation causes early carcinogenesis and results in increased metastatic spread as well as poor survival rates in breast cancer and lung cancer 27, 28 . In comparison to the benign MCF10A cell line, the impact of GIRK1 overexpression on motility of the malign MCF7 cell line was less pronounced. Nevertheless, these findings corroborate our previous observation of increased migration of MCF7 GIRK1/eYFP compared to controls 18 . Upon GIRK1 overexpression, wound healing was highly impaired observed a small increase in wound healing rate upon overexpression of GIRK1/eYFP chimeric protein in the malignant MCF7 line, but a decrease when GIRK1 function was knocked out through overexpression of the dominant negative splice variant GIRK1d 18 . Hence, marginal GIRK1 levels, as observed in MCF7 WT , have negative bearing on wound healing. Impairment of wound healing is considered a cancer hallmark 29 and is co-opted as element of the developmental regulatory program, referred to as the "epithelial-mesenchymal transition" (EMT), by which transformed epithelial cells are able to acquire the abilities to invade, to resist apoptosis, and to disseminate 30 . Transcriptional downregulation of the gene cluster "wound healing" was revealed by transcriptome analysis (see heat map "wound healing"; Fig. 3C ). Among the genes, downregulated in MCF10A GIRK1 and linked to impairment of wound healing, were DOCK8 and CD36 that are relevant players in breast cancer 24, 31 . Breast cancer is often associated with massive alterations of ECM architecture and composition, influencing a number of biological activities such as cell proliferation, differentiation, biosynthetic ability, polarity, locomotion and mechanical stress via structurally different surface receptors 32 . GIRK1 protein possesses an extracellular integrin www.nature.com/scientificreports www.nature.com/scientificreports/ binding motif 33 and hence may contribute to cell-ECM interactions. In the present study, overexpression of GIRK1 in MCF10A led to reduced adherence to surfaces coated with various extracellular matrix molecules. These experimental observations were reflected by downregulation of genes comprised in a functional cluster termed "Extracellular matrix -receptor interaction" (Fig. 3C ). Among the identified transcripts, downregulation of COL6A2, SERPINA1, CCBE1, TFPI2, THBS1 and COL8A1 have been shown to promote migration and invasion of malign breast cancer cells, aggravate metastatic spread and result in poor prognosis of breast cancer patients 25, [34] [35] [36] [37] . Based on preclinical experiments, using the malignant MCF7 line, Chen et al. 35 suggested that low SERPINA1 expression levels may be a strong indicator for bad response of ER + and ER + /HER2 + breast tumors to anti-ER as well as anti-HER2 therapies. Both the MCF10A as well as the MCF7 cell lines did not display alterations in proliferation, ability to form colonies upon seeding on petri dishes nor in growth rates of the colonies formed. Rezania et al. 18 obtained similar results upon overexpression of chimeric GIRK1/eYP protein in the malignant MCF7 cell line. The lack of effect of GIRK1 overexpression on cell proliferation is, to some extent, unexpected since GIRK1 overexpression in MCF10A has induced resilient changes in several gene clusters involved in cell division and proliferation. We hypothesize that the alterations in gene expression observed may require intrinsic factors from e.g. the tumor microenvironment, that are missing in our 2D cell culture, to become manifest in the functional phenotype. The gene clusters discussed above exert protumorigenic action upon downregulation. The most prominently regulated functional cluster is, however, upregulated and comprises downstream elements which are triggered by the cytokine interferon-γ (IFγ; "Interferon-γ response" (Fig. 3C) ). Canonical IFγ signaling causes activation of transmembrane IFγ receptors (IFγR1 and IFγR2), subsequent activation of JAK tyrosine kinases, binding and nuclear translocation of STAT proteins and subsequent activation of transcription factors such as interferon response factors (IRFs 38 ). Under physiological settings, IFγ signaling brings about biological functions related to antibacterial and antiviral host defense and immune regulation, cell cycle, apoptosis, inflammation and innate and acquired immunity 38 . The resilient immunomodulatory functions implicated in IFγ signaling prompted several clinical applications for the cure of chronic granulomatous disease, fungal infections, autoimmune diseases and cancer 39 . At about the same time that IFγ was regarded a promising antitumor agent, IFγ had been identified to exert another, vicious, side and to promote metastatic spread, resistance against natural killer cells, anti-apoptotic and proliferative responses of various malignant cell types (see 40, 41 , for review) and, in the pathophysiological context of malignant cells and microenvironment, acts pro-tumorigenic 42 . When screening radiation-and chemotherapy-resistant tumors, Khodarev et al. 43 and Weichselbaum et al. 44 discovered a gene signature, termed interferon-related DNA damage resistance signature (IRDS), because the majority of the genes identified were stimulated by interferon and are activated during antiviral response. In breast cancer, IRDS genes are regulated by exosome transfer from stroma cells, mediate resistance to radiation-and chemo-therapy, predict poor prognosis and are enriched in cells exerting cancer stem cell like features 45 . In the present study, overexpression of GIRK1 in the benign MCF10A line triggered enhanced expression of several IRDS genes such as IFI6, IFI27, IFI44, IFIT1, IFIT3, IRF7 and ISG15, indicating a shift towards this awkward signature. Among the most strongly upregulated downstream IFγ signaling elements are IFI6, DCLK1 and LCN2, which have been shown to promote migration, invasion and metastasis formation of malignant MECs and to correlate with poor prognosis for patients ( [46] [47] [48] . Likewise, the type 1 interferon/IRF7 axis has been shown to bring about chemotherapy-induced immunological dormancy in breast cancer 49 . This is the first study to provide insight into the cellular and molecular consequences of GIRK1 overexpression in benign MCF10A cells. Our study reveals that the overexpression of a single K + channel subunit shifts vital parameters of a benign MEC line towards cancer hallmarks. Expression levels of a sizeable number of transcripts, several of them involved in induction, progression and resistance to the therapy of treatment of breast cancer, accompanies the changes in cellular behavior. The observed influence on cellular behavior goes well beyond the role of overexpression of a K + ionophore acting on cellular motility via topical osmoregulatory K + levels alone. It indicates that GIRK1 may represent a missing link for the complementation of pathophysiological de-novo pathways that alter cellular homeostasis towards the malign phenotype. This is in accordance with the observation of excessive GIRK1 mRNA and protein levels in breast tumors that correlate with poor prognosis for patients with ER + breast cancer 14 . Hence, the future and detailed investigation of GIRK1 mediated pathways in MECs is 
Materials and Methods
Commercial providers of chemicals and reagents are listed in Supplementary Table S1 . All chemicals were reagent grade, unless stated otherwise.
Cell culture and media. MCF7 cells were maintained in MEM supplemented with 10% FBS, 1% L-Glutamine, 1% Sodium Pyruvate and Penicillin-Streptomycin (100 U/ml and 100 ng/ml) at 37 °C with 5% CO 2 . MCF10A cells were cultured in MEBM medium including SingleQuots and 0,004% CT. WT cell lines were used between passages P27 to P35 and split every 3 to 5 days. Stably transfected cell lines were used since generation as follows: MCF7 eGFP : P8-P13; MCF7 GIRK1 : P10-P16; MCF10A eGFP : P7-P13; MCF7 GIRK1 : P11-P16. All cell lines were free of mycoplasma contamination, as tested routinely. To prove the common origin of MEC lines, short tandem repeat (STR) profiling of the parental cell lines was performed. All markers (CSF1PO, DSS818, D13S317, D7S820, D16S539, vWA, TH01, TPOX and Amelogenin) indicated integrity of the cell lines.
Constructs and transfection.
For the generation of stable constructs, the coding sequence of human GIRK1 was amplified by PCR (NM_002239.3; primers used: plasmid-GIRK1a-f, plasmid-GIRK1a-r; see Supplementary Table S2 for sequence), digested with NheI and BamHI and cloned into the cloning site of . WT: MCF10A WT , eGFP: MCF10A eGFP and GIRK1: MCF10A GIRK1 . Box plots represent median value, 25% and 75% percentiles, respectively. Mean values are indicated by red line. Whiskers denote 10% and 90% percentiles. Single scores outside the 10% and 90% percentiles are depicted as black circles. Number of individual onplants is given in parenthesis above each box. Differences were not significant at the statistical level. (C) Onplant area after 4 days of growth. WT: MCF10A WT , eGFP: MCF10A eGFP and GIRK1: MCF10A GIRK1 . Box plots represent median value, 25% and 75% percentiles, respectively. Mean values are indicated by red line. Whiskers denote 10% and 90% percentiles. Black circles denote single values outside the 10% and 90% percentiles. Number of individual onplants is given in parenthesis above each box. P-values for statistically significant differences are indicated above brackets (n.s.: statistically not significant).
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(2019) 9:19277 | https://doi.org/10.1038/s41598-019-55683-w www.nature.com/scientificreports www.nature.com/scientificreports/ pIRES2eGFP. Sanger sequencing verified the sequence of the entire construct. For stable transfection, the pIRE-S2eGFP plasmid was linearized with AseI. Stable transfection of MCF10A or MCF7 cells was achieved using Lipofectamine following the manufacturer's protocol. 24 h after successful transfection, as verified by fluorescence microscopy, appropriate medium supplemented with G418 was added (16 mg/mL for MCF10A and 3 mg/mL for MCF7, respectively). After 5 to 7 days of growth, transfected cells were isolated by cell sorting using eGFP fluorescence as reporter acquired on a LSRII (BD Bioscience, Vienna, Austria). Stable transfection was verified by routinely checking the cells for fluorescence by microscopy throughout the duration of the investigation.
RNA isolation. Cells were grown to 70-80% confluence, harvested by trypsinization and spun at 750 rpm for 3 minutes. RNA was isolated from cell-pellet using QIA shredder spin column and RNeasy Mini Kit according to manufacturer's protocol.
Transcriptome analysis by next-generation sequencing. 10 ng of isolated RNA was heat inactivated for 10 min at 80 °C followed by cDNA Synthesis using the SuperScript VILO cDNA synthesis kit. DNA library was generated using the Ion AmpliSeq Transcriptome Human Gene Expression kit according to manufacturers' instructions. Sequencing was performed on Ion S5 XL benchtop sequencer (Thermo Fisher Scientific) to a length of 200 base pairs. On average 8 million reads were sequenced per sample. Data analysis was performed using the Ampliseq RNA Transcriptome workflow of the Ion Torrent suite. Briefly, amplicons were mapped to a human transcriptome reference (AmpliSeq_Transcriptome_21K.v1) and mapping reads were counted for each transcript and exported to a tabular file. Differentially expressed genes between GIRK1 and eGFP expressing cells were defined through 2-fold difference and a coefficient of variation below 0.7 between the two replicates. DAVID functional clustering was performed with up-and downregulated genes separately, selecting gene ontology (GO) biological processes and KEGG pathways 50, 51 . Significant enrichment was determined via false discovery rate (FDR) and/or Benjamini-Hochberg corrected value. Heat maps were generated using Genesis 52 . RNA-seq expression of six genes, selected from the clusters "IFγ", "ECM" and "migration" was confirmed by independent qPCR (Validation of RNA-seq data is shown in Supplementary Figure S5 ). Original data have been deposited in NCBI's Gene Expression Omnibus (Accession number: GSE138155; GEO; https://www.ncbi.nlm.nih.gov/geo/).
qPCR.
For converting to cDNA, QuantiTect Rev the Transcription kit was used according to manufacturer's protocol. The obtained cDNA was diluted 1:25 and quantitative real-time PCR was performed with the Thermal Cycler C1000 Touch in 96-well plates, using QuantiFast SYBR Green PCR Kit, according to manufacturers' instructions. All samples were measured in triplicate. The relative mRNA expression levels of GIRK1 gene compared to the housekeeping genes YWHAZ and GAPDH were calculated using the 2 ΔΔCt method 53 . GIRK1 mRNA levels were normalized to the one of MCF10A WT (See Supplementary Table S2 for primer sequences).
Western blot analysis.
For preparation of protein lysate from MCF10A and MCF7 cell lines, two TC Dishes 35 mm at 90% confluence were used. Cells were washed twice with ice-cold PBS and lysed in 200 µl Frackelton buffer including complete Mini Protease inhibitor Cocktail tablet. Lysates were sonicated for 30 minutes, using an ultrasound device (ECONO-Clean TVEN), followed by centrifugation at 13200 rpm (4 °C; 15 min). Protein concentration was determined 54 . In each slot 3 µg protein were loaded onto 12% SDS gels 55 . Spectra Multicolor protein ladder was used as standard. After electro transfer (150 mA, on ice; transfer buffer) on Immobilon-P PVDF, protein bands were located by staining with Ponceau S solution (0,5% diluent) according to the manufacturer's instructions. Membranes were blocked with 3% Difco Skim Milk in TBST (Tris-buffered saline containing Tween 20) for 30 minutes at room temperature and incubated with primary Ab (overnight; 4 °C). The membranes were washed (3×) with 3% Difco Skim Milk in TBST for 10 minutes and incubated with the secondary antibody (1 hour in room temperature). After incubation with ECL-Select antibody-protein complexes were analyzed by ChemiDoc Imager (BioRad, ChemiDoc MP). The following combinations of primary and secondary antibodies were used: #1.: GIRK1 CT Ab (APC-005, directed against GIRK1 C-terminus; Alomone labs, Jerusalem, Israel, rabbit polyclonal) dilution 1:800 in 5% [w/v] BSA with Peroxidase Goat anti-rabbit as secondary Ab Immunoprecipitation. MCF7 cells in T75 culture flask at 90% confluence were lysed in 500 µl Frackelton buffer as described under methods for WB. After centrifugation, 150 µl Protein A Agarose was added to the supernatant and incubated for 1 hour at 4 °C. The sample was centrifuged at 4000 rpm (3 minutes, 4 °C). 15 µl GIRK1 (Alomone) antibody (see WB) was added to the supernatant and incubated overnight at 4 °C. 225 µl Protein A agarose suspension was added and incubated at room temperature for 2 hours. The probe was centrifuged a 4000 rpm (3 minutes, 4 °C). After washing with 500 µl Frackelton buffer (3 × ), 30 µl 4x Laemmli buffer was added and incubated (95 °C, 5 minutes) followed by centrifugation (3 min 4000 rpm at RT) and WB analysis was performed. www.nature.com/scientificreports www.nature.com/scientificreports/ Wound healing assay. Cells (1,5 × 10 5 /well) were seeded into 24 well plates. After growing to 90% confluency and using a 200 µl pipette tip, a scratch was made across the center of the well, producing an interruption of the cell monolayer, resulting in a scratch, the width of which was approximately 1 mm. Detached and damaged cells were removed by carefully aspirating the medium and rinsing with PBS before the addition of 700 µl fresh MEBM growth medium. The plates were monitored for 24 h (MCF10A derived lines) or 36 h (MCF7 derived lines) in a Cell Observer (Zeiss Axiovert 200 M) at intervals of 20′ (MCF10A) or 30′ (MCF7), respectively. For analyzing the data, ImageJ 56 software (1.51j8) and a custom developed macro termed ALGov9 was used (see supplementary materials for complete code).
Cell adhesion assay. The colorimetric CHEMICON ECM Cell Adhesion
Chick chorioallantoic membrane assay. Fertilized white Lohmann chicken eggs were obtained from a local hatchery (Schropper GmbH, Gloggnitz, Austria). The egg shell was cracked on day 3 of embryonic development and embryos were placed into sterilized plastic dishes for further incubation for 7 days in a MultiQuip incubator at 37 °C (50% humidity). MCF10A cells were applied in volumes of 15 µL in a 1:1 mixture with Matrigel (10 6 cells/onplant) within 5 mm silicone rings. Silicone rings were placed on vascular branches of the CAM. After 4 days of incubation the progression of tumor growth was monitored by photo-documentation (Olympus SZX16). The formed tumors were photographed and neovascularization was scored according to 57 . Onplant area was analyzed by IQM 58 .
Proliferation assay. Cells (2 × 10 5 ) were seeded in 6 well plates and incubated in cell culture incubator with MEBM growth medium. 5-ethynyl-2′-deoxyuridine (EdU) was used to directly measure cells in the S-phase 59 . The Click-iT EdU Pacific Blue Flow Cytometry Assay Kit was used according to the manufacturer's protocol. After reaching 70-80% confluency, a 10 mM solution of EdU of the Click-iT EdU Assay was added to each well. After 3 hours incubation time, cells were harvested and washed with 3 mL 1% BSA in PBS. Cells without staining and treatment were taken for control in all experiments. To define cell cycle (G 1 /G 0 -; S-and G 2 /M-phases), the fluorescent DNA binding dye 7-AAD viability staining solution (PerCP-A) was used. Flow cytometry of 500 µl cell suspension was performed using LSRII (BD Bioscience, Vienna, Austria). Data were analyzed with DIVA software (BD Bioscience).
Colony formation assay. One hundred single MCF10A cells were seeded in 1000 µl medium per well in six well plates. For MCF7, 200 single cells were seeded. Following 8 days of culture, plates were washed with PBS solution and fixed for 5 minutes with fixing solution (85% Methanol; 15% Acetic acid). After washing with distilled water the plates were incubated for 2 hours with 1000 µl 0,5% crystal violet stain solution per well, washed with distilled water and air dried at room temperature. The plates were scanned with CanonScan 4400 F. Colony sizes were measured using ImageJ software (1.51j8).
Electrophysiological recording and analysis. MCF10A and MCF7 cells were seeded on 6 × 6 mm coverslips in 24 well plates, cultured as described for more than 24 h before electrophysiological experiments were started. For recording, the coverslips were transferred to a bathing chamber in bathing solution (NaBS) mounted to the stage of an inverted microscope (IM35, Zeiss, Germany). Using whole cell patch clamp method and nystatin perforation as previously described 60 , resting membrane potentials were recorded at RT not longer than 20 minutes after the cells were removed from the incubator. Briefly, nystatin stock solution (NSS) was prepared by dissolving nystatin (N6261, Merck, Darmstadt, Germany) in DMSO (analytical grade, Merck, Darmstadt, Germany) at a concentration of 50 mg/mL, aliquoted and stored at −20 °C until use. Nystatin containing pipette solution (PSN) was prepared by pipetting 200 μL NSS into 10 mL pipette filling solution (PFS; in 15 mL Falcon tube) under sonication using ultrasonic cleaning bath (Emmi-H22, EMAG AG, Mörfelden-Walldorf, Germany). After nystatin addition, PSN was sonicated for one additional minute, stored on ice and filtered (Wahtman Rotrand 0, 2 μm, FP30/0,2-CA-510462200, Fisher Scientific) immediately before use. Patch clamp pipettes were pulled from borosilicate glass capillaries (Assistent Mikro-Haematokrit capillary tubes, Hecht, Fisher Scientific; final resistance was 1-2.5 MΩ). After Gigaseal formation, perforation was monitored by capacitance measurements. After successful perforation, as judged by capacitance >25 pF, resting membrane potential was low pass filtered at 50 Hz and recorded for 20 seconds using Axopatch-200A amplifier (Molecular Devices, USA). Traces were digitized at 1 kHz using the Digidata 1322 A interface (Molecular Devices, USA) using Clampex 9.2 software (Molecular Devices, USA). Membrane resting potential was measured by averaging the entire trace using the Clampfit 10.3 software (Molecular Devices, USA). The composition of solutions used was as follows (concentrations given in parenthesis in mmol/L): NaBS: KCl (2), NaCl (148), MgCl 2 (4), CaCl 2 (1) and HEPES (10), buffered with NaOH to pH:7.4. PFS: KCl (20), K + /aspartate − (120), NaCl (10), MgCl 2 (4), EGTA − /K + (1) and HEPES, buffered with KOH to pH: 7.4.
Motility analysis.
Cell movement was recorded and analyzed as described previously 61 , with a recording rate of 3 images per hour over a period of 3 days. Analysis of motility coefficients and cellular velocities was limited to the time interval, when movement was not constrained by the developing cell bulk, using median cell displacement as an indicator. Average cellular velocities were calculated separately for cells that were free or aggregated (defined as cells that were in contact with neighboring cells with >50% of their perimeter).
Statistical analysis. Statistical analysis of data was performed using SPSS embedded in Sigmaplot (SPW 14.0, Systat Software Inc.). In short, datasets consisting of more than two experimental groups were tested for normal distribution and one way or rank based ANOVA was performed as appropriate. Subsequent pairwise comparisons were performed using appropriate algorithms. For the comparison of two experimental groups, student's t-test was used. Statistics for cell migration was computed with public domain software R, version 3.5.3
and RStudio software version 1.1.463 (RStudio Team (2016), R Core Team 2019). In case of MCF10A cells, means of data were analysed with a bootstrap-t method based ANOVA using the R function t1waybt (Wilcox 2017), followed by post hoc tests using the R function linconbt allowing also a comparison of all pairs of groups. In case of MCF7 cells, due to pronounced skewness, medians were analysed with a percentile bootstrap method using the R function Qanova followed by pairwise median comparisons using a percentile bootstrap method implemented in the R function medpb 62 . Holm method was used for adjustment of p-values due to multiple comparisons. To compare deciles the R function, qcomhfMC 62 was used combining a percentile bootstrap method with a quantile estimator allowing tied values.
